Bristol-Myers Squibb

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. 

CEO
Christopher S. Boerner
CEOChristopher S. Boerner
Employees
34,100
Employees34,100
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1933
Founded1933
Employees
34,100
Employees34,100

BMY Key Statistics

Market cap
97.49B
Market cap97.49B
Price-Earnings ratio
19.54
Price-Earnings ratio19.54
Dividend yield
5.08%
Dividend yield5.08%
Average volume
9.52M
Average volume9.52M
High today
$49.10
High today$49.10
Low today
$47.72
Low today$47.72
Open price
$48.73
Open price$48.73
Volume
11.60M
Volume11.60M
52 Week high
$63.33
52 Week high$63.33
52 Week low
$42.96
52 Week low$42.96

BMY News

TipRanks 5h
Bristol-Myers Squibb’s Promising Phase 3 Study on KarXT for Bipolar-I Disorder

Bristol-Myers Squibb Company ((BMY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

TipRanks 5h
Bristol-Myers Squibb’s New Lung Cancer Study: Potential Market Impact

Bristol-Myers Squibb Company ((BMY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...

TipRanks 5h
Bristol-Myers Squibb’s Luspatercept Study: Market Insights and Implications

Bristol-Myers Squibb Company ((BMY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

Analyst ratings

74%

of 27 ratings
Buy
22.2%
Hold
74.1%
Sell
3.7%

More BMY News

TipRanks 5h
Bristol-Myers Squibb’s New Lung Cancer Study: Market Implications and Progress

Bristol-Myers Squibb Company ((BMY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

TipRanks 1d
Bristol-Myers Squibb’s Promising Phase 3 Study on Pulmonary Fibrosis: A Potential Game Changer?

Bristol-Myers Squibb Company ((BMY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

TipRanks 1d
Bristol-Myers Squibb’s New Study: A Potential Game Changer in Multiple Myeloma Treatment

Bristol-Myers Squibb Company ((BMY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

TipRanks 2d
Bristol-Myers Squibb’s New Study on Pancreatic Cancer Treatment: What Investors Need to Know

Bristol-Myers Squibb Company ((BMY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

Seeking Alpha 4d
FDA grants breakthrough status to Bristol drug with SystImmune for lung cancer

Healthcare FDA grants breakthrough status to Bristol drug with SystImmune for lung cancer Aug. 18, 2025 7:11 AM ET Bristol-Myers Squibb Company (BMY) Stock By:...

FDA grants breakthrough status to Bristol drug with SystImmune for lung cancer

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.
UPS
Caterpillar
Equinix
Salesforce
Intel
Micron Technology
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.